{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T16:54:31Z","timestamp":1686070471628},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T00:00:00Z","timestamp":1414368000000},"content-version":"vor","delay-in-days":240,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1053\/j.jrn.2013.11.001","type":"journal-article","created":{"date-parts":[[2014,1,10]],"date-time":"2014-01-10T16:20:46Z","timestamp":1389370846000},"page":"65-71","source":"Crossref","is-referenced-by-count":7,"title":["Toward Individualized Cholesterol-Lowering Treatment in End-Stage Renal Disease"],"prefix":"10.1053","volume":"24","author":[{"given":"Guenther","family":"Silbernagel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried","family":"M\u00e4rz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2013.11.001_bib1","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2013.11.001_bib2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa0706728","article-title":"Polymorphisms associated with cholesterol and risk of cardiovascular events","volume":"358","author":"Kathiresan","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2013.11.001_bib3","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/j.ajkd.2009.06.029","article-title":"Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus","volume":"54","author":"Krane","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.11.001_bib4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2215\/CJN.09961110","article-title":"Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients","volume":"6","author":"Shoji","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.11.001_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.291.4.451","article-title":"Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition","volume":"291","author":"Liu","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2013.11.001_bib6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1681\/ASN.2006060674","article-title":"Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome","volume":"18","author":"Kovesdy","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.11.001_bib7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1681\/ASN.2007101128","article-title":"Lipid abnormalities and cardiovascular risk in renal disease","volume":"19","author":"Ritz","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.11.001_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"key":"10.1053\/j.jrn.2013.11.001_bib9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1053\/j.jrn.2013.11.001_bib10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data\u00a0from 170 000 participants in 26 randomised trials","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"10.1053\/j.jrn.2013.11.001_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2013.11.001_bib12","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2013.11.001_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MOL.0b013e328353292e","article-title":"Plasma non cholesterol sterols: current uses, potential and need for standardization","volume":"23","author":"Mackay","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"10.1053\/j.jrn.2013.11.001_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pharmthera.2010.02.006","article-title":"Molecular pathways and agents for lowering LDL-cholesterol in addition to statins","volume":"126","author":"Costet","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1053\/j.jrn.2013.11.001_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2013.01.100","article-title":"High intestinal cholesterol absorption is associated with cardiovascular disease and risk alleles in ABCG8 and ABO: evidence from the LURIC and YFS cohorts and from a meta-analysis","volume":"62","author":"Silbernagel","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jrn.2013.11.001_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1194\/jlr.P800013-JLR200","article-title":"The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease","volume":"50","author":"Silbernagel","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1053\/j.jrn.2013.11.001_bib17","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1194\/jlr.P002899","article-title":"The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality","volume":"51","author":"Silbernagel","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1053\/j.jrn.2013.11.001_bib18","doi-asserted-by":"crossref","first-page":"361863","DOI":"10.1155\/2012\/361863","article-title":"Cholesterol synthesis is associated with hepatic lipid content and dependent on fructose\/glucose intake in healthy humans","volume":"2012","author":"Silbernagel","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1053\/j.jrn.2013.11.001_bib19","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2337\/diabetes.53.9.2217","article-title":"Cholesterol metabolism in type 1 diabetes","volume":"53","author":"Gylling","year":"2004","journal-title":"Diabetes"},{"key":"10.1053\/j.jrn.2013.11.001_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/oxfordjournals.aje.a115479","article-title":"Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population","volume":"131","author":"Miettinen","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.jrn.2013.11.001_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0026-0495(89)90252-7","article-title":"Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men","volume":"38","author":"Miettinen","year":"1989","journal-title":"Metabolism"},{"key":"10.1053\/j.jrn.2013.11.001_bib22","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1373\/clinchem.2012.189605","article-title":"Gas chromatography-tandem mass spectrometry method for the simultaneous determination of oxysterols, plant sterols, and cholesterol precursors","volume":"58","author":"Matysik","year":"2012","journal-title":"Clin Chem"},{"key":"10.1053\/j.jrn.2013.11.001_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MOL.0b013e32835b6271","article-title":"Plant sterols and atherosclerosis","volume":"24","author":"Silbernagel","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1053\/j.jrn.2013.11.001_bib24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2006.07.030","article-title":"The distribution of squalene and non-cholesterol sterols in lipoproteins in type 2 diabetes","volume":"19","author":"Simonen","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.jrn.2013.11.001_bib25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJM198503283121301","article-title":"Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial","volume":"312","author":"Arntzenius","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2013.11.001_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-145-1-200607040-00004","article-title":"Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial","volume":"145","author":"Estruch","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jrn.2013.11.001_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2012.09.018","article-title":"Progress and prospective of plant sterol and plant stanol research: report of the Maastricht meeting","volume":"225","author":"Plat","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.jrn.2013.11.001_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3945\/jn.108.095125","article-title":"Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake","volume":"139","author":"Demonty","year":"2009","journal-title":"J Nutr"},{"key":"10.1053\/j.jrn.2013.11.001_bib29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2013.11.001_bib30","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/01.ATV.20.5.1340","article-title":"Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol","volume":"20","author":"Miettinen","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.jrn.2013.11.001_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0021-9150(01)00608-6","article-title":"Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients","volume":"160","author":"Gylling","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.jrn.2013.11.001_bib32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.atherosclerosis.2011.06.010","article-title":"Where does the interplay between cholesterol absorption and synthesis in the context of statin and\/or ezetimibe treatment stand today?","volume":"217","author":"Descamps","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.jrn.2013.11.001_bib33","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/bmj.316.7138.1127","article-title":"Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators","volume":"316","author":"Miettinen","year":"1998","journal-title":"BMJ"},{"key":"10.1053\/j.jrn.2013.11.001_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MOL.0b013e3283613a55","article-title":"Ezetimibe and bile acid sequestrants: impact on lipoprotein metabolism and beyond","volume":"24","author":"Couture","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1053\/j.jrn.2013.11.001_bib35","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1161\/01.CIR.0000034044.95911.DC","article-title":"Inhibition of intestinal cholesterol absorption by ezetimibe in humans","volume":"106","author":"Sudhop","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2013.11.001_bib36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0195-668X(02)00807-2","article-title":"Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia","volume":"24","author":"Knopp","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jrn.2013.11.001_bib37","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2013.11.001_bib38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCULATIONAHA.110.006692","article-title":"Combined effects of ezetimibe and phytosterols on cholesterol metabolism: a randomized, controlled feeding study in humans","volume":"124","author":"Lin","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2013.11.001_bib39","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000116766.31036.03","article-title":"Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia","volume":"109","author":"Salen","year":"2004","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2013.11.001_bib40","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ahj.2008.07.023","article-title":"Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe\/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes","volume":"156","author":"Cannon","year":"2008","journal-title":"Am Heart J"},{"key":"10.1053\/j.jrn.2013.11.001_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MOL.0b013e32834f0ef3","article-title":"Bile acid sequestrants: more than simple resins","volume":"23","author":"Out","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"10.1053\/j.jrn.2013.11.001_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.CIR.69.2.313","article-title":"Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study","volume":"69","author":"Brensike","year":"1984","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2013.11.001_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1984.03340270029025","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2013.11.001_bib44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1525-139X.2008.00440.x","article-title":"Nonphosphate-binding effects of sevelamer\u2013are they of clinical relevance?","volume":"21","author":"Marangon","year":"2008","journal-title":"Semin Dial"},{"key":"10.1053\/j.jrn.2013.11.001_bib45","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/ndt\/14.12.2907","article-title":"Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients","volume":"14","author":"Chertow","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2013.11.001_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5414\/CNP62104","article-title":"Long-term comparison of a calcium-free phosphate binder and calcium carbonate\u2013phosphorus metabolism and cardiovascular calcification","volume":"62","author":"Braun","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.jrn.2013.11.001_bib47","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.11.001_bib48","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.11.001_bib49","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.11.001_bib50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.amjcard.2004.06.008","article-title":"Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia","volume":"94","author":"Xydakis","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jrn.2013.11.001_bib51","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2215\/CJN.05170511","article-title":"Cholesterol synthesis, cholesterol absorption, and mortality in hemodialysis patients","volume":"7","author":"Rogacev","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.11.001_bib52","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1253\/circj.CJ-11-1302","article-title":"Cholesterol metabolism in patients with hemodialysis in the presence or absence of coronary artery disease","volume":"76","author":"Fukushima","year":"2012","journal-title":"Circ J"},{"key":"10.1053\/j.jrn.2013.11.001_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM198101083040201","article-title":"Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study","volume":"304","author":"Shekelle","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2013.11.001_bib54","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2013.11.001_bib55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/j.ajkd.2011.03.032","article-title":"Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis","volume":"58","author":"Slinin","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.11.001_bib56","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1053\/j.jrn.2010.09.001","article-title":"Dietary intake in hemodialysis patients does not reflect a heart healthy diet","volume":"21","author":"Khoueiry","year":"2011","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2013.11.001_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/01.CIR.14.1.77","article-title":"The effect of beta sitosterol on the serum lipids of young men with arteriosclerotic heart disease","volume":"14","author":"Dempsey","year":"1956","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2013.11.001_bib58","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/eurheartj\/ehn580","article-title":"Controversial role of plant sterol esters in the management of hypercholesterolaemia","volume":"30","author":"Weing\u00e4rtner","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jrn.2013.11.001_bib59","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1161\/CIR.0b013e318212bb8b","volume":"123","author":"Anderson","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2013.11.001_bib60","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"European Association for Cardiovascular Prevention & Rehabilitation","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jrn.2013.11.001_bib61","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/jn\/137.5.1301","article-title":"Customary use of plant sterol and plant stanol enriched margarine is associated with changes in serum plant sterol and stanol concentrations in humans","volume":"137","author":"Fransen","year":"2007","journal-title":"J Nutr"},{"key":"10.1053\/j.jrn.2013.11.001_bib62","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/eurheartj\/ehr441","article-title":"Plant sterols and cardiovascular disease: a systematic review and meta-analysis","volume":"33","author":"Genser","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jrn.2013.11.001_bib63","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/CIRCGENETICS.109.907873","article-title":"Genetic regulation of serum phytosterol levels and risk of coronary artery disease","volume":"3","author":"Teupser","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1053\/j.jrn.2013.11.001_bib64","doi-asserted-by":"crossref","first-page":"e1002260","DOI":"10.1371\/journal.pgen.1002260","article-title":"Large-scale gene-centric analysis identifies novel variants for coronary artery disease","volume":"7","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1053\/j.jrn.2013.11.001_bib65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-scale association analysis identifies new risk loci for coronary artery disease","volume":"45","author":"Deloukas","year":"2013","journal-title":"Nat Genet"},{"key":"10.1053\/j.jrn.2013.11.001_bib66","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1053\/j.jrn.2013.11.001_bib67","doi-asserted-by":"crossref","first-page":"986","DOI":"10.5551\/jat.13391","article-title":"Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration\/activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: therapeutic effects of ezetimibe","volume":"19","author":"Sato","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"10.1053\/j.jrn.2013.11.001_bib68","article-title":"Oxidised plant sterols as well as oxycholesterol increase the proportion of severe atherosclerotic lesions in female LDL receptor+\/- mice","author":"Plat","year":"2013","journal-title":"Br J Nutr"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227613002082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227613002082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T05:27:56Z","timestamp":1565069276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227613002082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1051227613002082"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2013.11.001","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}